Novozymes A/S (OTCMKTS:NVZMY) Sees Large Drop in Short Interest

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) was the recipient of a significant decline in short interest in February. As of February 13th, there was short interest totaling 5,586 shares, a decline of 79.5% from the January 29th total of 27,243 shares. Based on an average daily volume of 109,725 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 109,725 shares, the days-to-cover ratio is presently 0.1 days.

Novozymes A/S Stock Up 0.8%

Shares of Novozymes A/S stock traded up $0.48 during trading on Thursday, hitting $58.57. 390,643 shares of the stock traded hands, compared to its average volume of 57,978. The company has a fifty day moving average price of $62.89 and a two-hundred day moving average price of $62.67. Novozymes A/S has a twelve month low of $53.95 and a twelve month high of $75.99. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 0.26.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

See Also

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.